BusinessCellaria Adds Next-Generation RNA Reprogramming and Stem Cell ServicesBy Nasdaq OMXMar 20, 2017, 12:43 PM UTC
BusinessCellaria Forms Strategic Partnership with AMS BiotechnologyBy Nasdaq OMXFeb 9, 2017, 5:11 PM UTC
BusinessCellaria to Release Novel Ovarian and Breast Cancer Cell ModelsBy Nasdaq OMXNov 15, 2016, 5:34 PM UTC
